Asthma Market Research Reports & Industry Analysis
The strongest risk factors for developing asthma are a person’s exposure to allergens and a family history of asthma or allergy. Exposure to tobacco smoke and exposure to chemical irritants in the workplace are additional risk factors. Workplace conditions, such as exposure to fumes, gases or dust, are responsible for 11% of asthma cases worldwide.
Asthma Industry Research & Market Reports
-
COPD and Asthma Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... expects the market to reach US$ 60.4 Billion by 2028, exhibiting a growth rate (CAGR) of 5.31% during 2023-2028. Chronic obstructive pulmonary disease (COPD) is an inflammatory disease that leads to obstructed airflow from the ... Read More
-
Asthma Therapeutics Market Intelligence Report - Global Forecast 2023-2030
... forecast period. Market Statistics: The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make better decisions. In ... Read More
-
2023 Global Asthma And Copd Drug Market Industry (2029 Outlook)
... data for a three-year historical trend (2017-2020), a three-year forecast estimate trends (2021-2023), and a five-year outlook projection (2024-2029) for 46 countries. Market and product shipments include the total value of all products produced and ... Read More
-
Chronic Obstructive Pulmonary Disease (COPD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... more than 126 million diagnosed prevalent cases of COPD across 16 pharmaceutical markets. There are a good number of marketed innovator drugs for the treatment of COPD, mostly receptor agonists. Among the pipeline molecules for ... Read More
-
Genetic Chronic Obstructive Pulmonary Disease (COPD) Market, By Drug Class (Bronchodilators, Phosphodiesterase Type 4 Inhibitors, Steroids, Antibiotics and Others), By Route of Administration (Oral and Nasal), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030
... Pharmacies), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030 Alpha-1 deficiency-related emphysema is called as genetic Chronic obstructive pulmonary ... Read More
-
Asthma & COPD Therapies Market Report 2023-2033
... industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region. Expansion into Emerging Markets to Offer ... Read More
-
Chronic Obstructive Pulmonary Disease (COPD) Market, Global Forecast 2023-2028, Industry Trends, Growth, Insight, Impact of Inflation, Company Analysis
... Renub Research. Chronic inflammatory lung disease causes breathing difficulties. It is a group of progressive lung diseases. The most common diseases are emphysema and chronic bronchitis. COPD, if left untreated, can lead to worsening respiratory ... Read More
-
Tonometry Device Market, by DeviceType (Applanation Tonometers, Pascal Dynamic Contour Tonometers, Rebound Tonometers, Indentation Tonometers), by Application (Heart failure, Hypertension, Arteriosclerosis, Others (COPD, and Diabetes etc.)), by End User (Hospitals, Specialty Clinics and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 Tonometry means "to measure pressure" while applanation means "to flatten out." Radial artery ... Read More
-
Oscillating Positive Expiratory Pressure Devices Market Analysis and Forecast to 2031: By Product Type (Face Mask PEP Devices, Mouthpiece PEP Devices, Bottle PEP Devices), Indication (COPD & Asthma, Bronchitis, Cystic Fibrosis, Others), End User (Hospital & Clinics, Ambulatory Surgical Centers, Others), and Region
... & Clinics, Ambulatory Surgical Centers, Others), and Region The oscillating positive expiratory pressure devices market was valued at USD 125.7 million in 2021 and it is anticipated to grow further till USD 208.9 million by ... Read More
-
China COPD & Asthma Market 2022-2028
... setting and Clinics Center) Forecast Period (2021-2028) The China Chronic obstructive pulmonary disease (COPD) & asthma market was valued at around $3.5 billion in 2021 and is estimated to reach nearly $4.7 billion in 2028, ... Read More
-
Nebulizer Market Forecasts to 2028 – Global Analysis By Type (Ultrasonic Nebulizer, Mesh Nebulizer and Compressed Jet Nebulizer), Portability (Portable Nebulizer and Tabletop Nebulizer), Application (Asthma, Cystic Fibrosis, Chronic Obstructive Pulmonary Disease (COPD) and Other Applications), End User and By Geography
... Applications), End User and By Geography According to Stratistics MRC, the Global Nebulizer Market is accounted for $1.12 billion in 2022 and is expected to reach $1.80 billion by 2028 growing at a CAGR of ... Read More
-
Asthma - Drug Pipeline Landscape, 2022
... also due to excess mucus. It is characterised by airflow obstruction and triggers bronchospasms. Signs and symptoms of asthma includes shortness of breath, chest tightness, recurrent episodes of wheezing and cough. These symptoms vary from ... Read More
-
Asthma Spacers Market Insights, Competitive Landscape and, Market Forecast - 2027
... IS EXPECTED TO RISE AT A SIGNIFICANT CAGR FORECAST TILL 2027 OWING TO THE ACCELERATING PREVALENCE OF ASTHMA AND OTHER RESPIRATORY DISORDERS AND SURGING EXPOSURE TO DUST, SMOKING, FUMES, AMONG OTHERS ACROSS THE GLOBE The ... Read More
-
Portable Oxygen Concentrators Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... pandemic had an effect on the market for portable oxygen concentrators as hospitals and healthcare services were drastically restricted as a result of social segregation policies implemented globally. The COVID-19 epidemic has put unprecedented pressure ... Read More
-
Chronic Obstructive Pulmonary Disease [COPD] Treatment Market (Drug Class: Combination Therapy, Bronchodilators, Corticosteroids, Phosphodiesterase Type 4 Inhibitor, Mucokinetics, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031
... (COPD) Treatment Market – Scope of Report TMR’s report on the global chronic obstructive pulmonary disease (COPD) treatment market studies the past as well as the current growth trends and opportunities to gain valuable insights ... Read More
-
Vaginal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... provides an overview of the Vaginal Cancer (Oncology) pipeline landscape. Vaginal cancer is a rare cancer that occurs in vagina. Symptoms includes watery vaginal discharge, a lump or mass in vagina, painful urination, constipation and ... Read More
-
South America Medical Oxygen Concentrators Market - 2022-2029
... growing at a CAGR of 7.2% during the forecast period (2022-2029). An oxygen concentrator is a device that concentrates the oxygen from a gas supply by selectively removing nitrogen to supply an oxygen-enriched product gas ... Read More
-
Asthma Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... than 260.6 million diagnosed prevalent cases of Asthma across 16 pharmaceutical markets. GSK is a key player in the disease space with four key products for asthma. Other main players include AstraZeneca, with two products, ... Read More
-
Pulmonary Function Testing System Market Forecasts to 2028 – Global Analysis By Type (Complete PFT Systems, Portable PFT Systems), Component (Hardware, Software, Service), Test Type (Lung Volume, Spirometry, Gas Exchange Testing, Oxygen Titration Test, Stethoscope), Component (Software, Hardware), Connectivity (Wireless, Wired), Application (Asthma, Chronic Shortness of Breath, Restrictive Lung Disease, Preoperative Testing), End User (Physical Examination (Diagnostic) Centers, Hospitals, Physician Groups (Clinics)), and By Geography
... Component (Software, Hardware), Connectivity (Wireless, Wired), Application (Asthma, Chronic Shortness of Breath, Restrictive Lung Disease, Preoperative Testing), End User (Physical Examination (Diagnostic) Centers, Hospitals, Physician Groups (Clinics)), and By Geography According to Stratistics MRC, the ... Read More
-
Therapeutic Respiratory Devices Market Size By Product (Positive Airway Pressure (PAP) Devices {Continuous Positive Airway Pressure [CPAP] Devices, Auto-titrating Positive Airway Pressure [APAP] Devices, Bi-level Positive Airway Pressure [BiPAP] Devices}, Oxygen Concentrators {Fixed Oxygen Concentrators, Portable Oxygen Concentrators}, Ventilators {Adult Ventilators, Neonatal Ventilators}, Inhalers {Metered Dose Inhaler [MDI], Dry Powder Inhaler [DPI], Soft Mist Inhaler [SMI]}, Nebulizers {Compressor-based Nebulizers, Piston-based Hand-held Nebulizers, Ultrasonic Nebulizers}, Humidifiers {Heated Humidifiers, Passover Humidifiers, Integrated Humidifiers, Built-in Humidifiers, Standalone Humidifiers}), By Application (COPD, Obstructive Sleep Apnea, Asthma, Respiratory Distress Syndrome, Cystic Fibrosis), By End-use (Hospital, Homecare Settings, Emergency Centers), Industry Analysis Report, Regional Outlook, Growth Potential, Covid-19 Impact Analysis, Competitive Market Share & Forecast,
... Portable Oxygen Concentrators}, Ventilators {Adult Ventilators, Neonatal Ventilators}, Inhalers {Metered Dose Inhaler [MDI], Dry Powder Inhaler [DPI], Soft Mist Inhaler [SMI]}, Nebulizers {Compressor-based Nebulizers, Piston-based Hand-held Nebulizers, Ultrasonic Nebulizers}, Humidifiers {Heated Humidifiers, Passover Humidifiers, Integrated ... Read More
-
Cytokine Market, By Cytokine Type (Tumor Necrosis Factor-TNF, Interleukins-II, Interferons-IFN, Epidermal Growth Factor-EGF, and Other Cytokine Types), By Therapeutic Application (Cancer, Asthma and Airway Inflammation, Arthritis, and Other Therapeutic Applications), and By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
... Europe, Asia-Pacific, Middle East and Africa, and South America) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Cytokines are a category of small proteins important in cell signaling. They are small proteins that ... Read More
-
Global Oxygen Therapy Market Size study, by Product (Oxygen Source Equipment, Oxygen Delivery Devices), by Application (Chronic Obstructive Pulmonary Disease, Asthma, Obstructive Sleep Apnea, Respiratory Distress Syndrome and Others), by End-Use (Hospitals and Home Healthcare) and Regional Forecasts 2022-2028
... and Regional Forecasts 2022-2028 Global Oxygen Therapy Market is valued at approximately USD XX Billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast ... Read More
-
XOLAIR Marketed Drug Insight and Market Forecast − 2032
... of the XOLAIR for Chronic Spontaneous Urticaria in 7MM, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for the study period 2019 –2032 is provided in this report along ... Read More
-
North America Inhalation and Nasal Spray Generic Drugs Market Size, Share & Industry Trends Analysis Report By End-user, By Indication (Asthma, Chronic Obstructive Pulmonary Disease (COPD), Allergic Rhinitis), By Distribution Channel, By Demographics, By
... and Growth Forecast, 2022 – 2028 The North America Inhalation and Nasal Spray Generic Drugs Market would witness market growth of 8.0% CAGR during the forecast period (2022-2028). Inhalation therapy involves dispersing medications into the ... Read More
-
Global Inhalation and Nasal Spray Generic Drugs Market Size, Share & Industry Trends Analysis Report By End-user, By Indication (Asthma, Chronic Obstructive Pulmonary Disease (COPD), Allergic Rhinitis), By Distribution Channel, By Demographics, By Regiona
... and Forecast, 2022 – 2028 The Global Inhalation and Nasal Spray Generic Drugs Market size is expected to reach $29.9 billion by 2028, rising at a market growth of 8.5% CAGR during the forecast period. ... Read More
Research Assistance
